| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| L | | IP | CI | | Binocrit 1000 IE/0,5 ml | 6 x 0.5 ml | 37.40 | 57.10 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 1000U.I. / 0.5ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | | | Binocrit 2000 IE/1 ml | 6 x 1 ml | 74.69 | 97.65 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 2000 UI/ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | | | Binocrit 3000 IE/0,3 ml | 6 x 0.3 ml | 111.97 | 138.20 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 3000U.I. / 0.3ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | | | Binocrit 4000 IE/0,4 ml | 6 x 0.4 ml | 149.15 | 178.65 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 4000U.I. / 0.4ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | | | Binocrit 5000 IE/0,5 ml | 6 x 0.5 ml | 186.61 | 219.35 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 5000U.I. / 0.5ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | | | Binocrit 6000 IE/0,6 ml | 6 x 0.6 ml | 223.73 | 259.75 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 6000U.I. / 0.6ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | | | Binocrit 8000 IE/0,8 ml | 6 x 0.8 ml | 297.96 | 340.45 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 8000U.I. / 0.8ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | | | Binocrit 10000 IE/1 ml | 6 x 1 ml | 372.82 | 421.90 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 10000 UI/ml | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 1000 U | 6 1 syringe(s) à 0.5 ml | 41.43 | 61.25 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 1000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 2000 U | 6 1 syringe(s) à 0.5 ml | 82.85 | 106.00 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 2000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 3000 U | 6 1 syringe(s) à 0.3 ml | 124.28 | 150.80 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 3000U.I. / 0.3ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 4000 U | 6 1 syringe(s) à 0.4 ml | 165.72 | 195.65 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 4000U.I. / 0.4ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 5000 U | 6 1 syringe(s) à 0.5 ml | 207.14 | 240.45 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 5000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 10000 U | 6 1 syringe(s) à 1 ml | 414.28 | 464.40 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 10000 UI/ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 20000 U | syringe(s) à 0.5 ml | 138.09 | 166.60 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 20000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 30000 U | syringe(s) à 0.75 ml | 207.14 | 241.70 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 30000U.I. / 0.75ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Eprex 40000 U | syringe(s) à 1 ml | 276.19 | 316.80 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 40000 UI/ml | Janssen-Cilag AG | A / SL | FB | | G | |
| L | | IP | CI | | Recormon PS 2000 U.I./0,3 mL | 6 | 84.49 | 108.30 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 2000U.I. / 0.3ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | CI | | Recormon PS 3000 U.I./0,3 mL | 6 | 126.75 | 154.25 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 3000U.I. / 0.3ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | CI | | Recormon PS 4000 U.I./0,3 mL | 6 | 168.99 | 200.20 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 4000U.I. / 0.3ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | CI | | Recormon PS 5000 U.I./0,3 mL | 6 | 211.24 | 246.15 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 5000U.I. / 0.3ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | CI | | Recormon PS 10'000
U.I./0,6 mL | 6 | 405.99 | 457.95 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 10000U.I. / 0.6ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | CI | | Recormon PS 30'000
U.I./0,6 mL | 4 | 811.98 | 899.50 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 30000U.I. / 0.6ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 1000 | 6 syringe(s) | 40.47 | 60.45 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 1000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 2000 | 6 syringe(s) | 80.96 | 104.45 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 2000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 3000 | 6 syringe(s) | 121.44 | 148.50 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 3000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 4000 | 6 syringe(s) | 161.93 | 192.50 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 4000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 5000 | 6 syringe(s) | 201.79 | 235.85 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 5000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 10'000 | 6 syringe(s) | 384.87 | 435.00 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 20'000 | 4 syringe(s) | 531.08 | 594.00 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | EpoTheta-Teva 30'000 | 4 syringe(s) | 780.15 | 864.90 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A / SL | FB | | G | |
| | | IP | | | Binocrit 7000 IE/0,7 ml | 6 x 0.7 ml | 586.75 | 707.35 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 7000U.I. / 0.7ml | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | | | Binocrit 9000 IE/0,9 ml | 6 x 0.9 ml | 754.50 | 904.90 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 9000U.I. / 0.9ml | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Eprex 6000 U | 6 1 syringe(s) à 0.6 ml | 364.87 | 435.25 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 6000U.I. / 0.6ml | Janssen-Cilag AG | A | FB | | G | |
| | | IP | CI | | Eprex 8000 U | 6 1 syringe(s) à 0.8 ml | 486.49 | 574.90 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 8000U.I. / 0.8ml | Janssen-Cilag AG | A | FB | | G | |
| | | IP | CI | | Eprex 30000 U | 4 1 syringe(s) à 0.75 ml | 1833.36 | 2070.20 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 30000U.I. / 0.75ml | Janssen-Cilag AG | A | FB | | G | |
| | | IP | CI | | Eprex 40000 U | 4 1 syringe(s) à 1 ml | 2444.42 | 2739.75 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 40000 UI/ml | Janssen-Cilag AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 1000 | 6 syringe(s) | 54.21 | 78.65 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 1000U.I. / 0.5ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 2000 | 6 syringe(s) | 108.42 | 140.85 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 2000U.I. / 0.5ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 3000 | 6 syringe(s) | 162.63 | 203.10 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 3000U.I. / 0.5ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 4000 | 6 syringe(s) | 216.84 | 265.35 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 4000U.I. / 0.5ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 10'000 | syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 10'000 | syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 10'000 | 4 syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 10'000 | 4 syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 5000 | 6 syringe(s) | 270.23 | 326.60 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 5000U.I. / 0.5ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 10'000 | 6 syringe(s) | 515.42 | 608.10 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 20'000 | syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 20'000 | syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 20'000 | 4 syringe(s) | 711.22 | 832.90 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 20'000 | 6 syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 20'000 | 6 syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 30'000 | syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 30'000 | syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 30'000 | 4 syringe(s) | 1044.76 | 1207.35 | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 30'000 | 6 syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | IP | CI | | EpoTheta-Teva 30'000 | 6 syringe(s) | PR | PR | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G | |
| | | | | | Recormon 500 U.I./0 | 10 ampoule(s) | PR | 130.40 | k.A. | | Injection preparation: Epoetinum Beta 500 UI | Roche Pharma
(Schweiz) AG | A | FB | | G | |
| | | | | | Recormon 1000 U.I./1 mL | 10 ampoule(s) | PR | PR | k.A. | | Injection preparation: Epoetinum Beta 1000 UI | Roche Pharma
(Schweiz) AG | A | FB | | G | |
| | | | | | Recormon 2000 U.I./1 mL | 10 ampoule(s) | PR | PR | k.A. | | Injection preparation: Epoetinum Beta 2000 UI | Roche Pharma
(Schweiz) AG | A | FB | | G | |
| | | | | | Recormon 5000 U.I./1 mL | 5 ampoule(s) | PR | 662.25 | k.A. | | Injection preparation: Epoetinum Beta 5000 UI | Roche Pharma
(Schweiz) AG | A | FB | | G | |
| | | | | | Recormon 10'000 U.I./mL | 5 ampoule(s) | PR | PR | k.A. | | Injection preparation: Epoetinum Beta 10000 UI | Roche Pharma
(Schweiz) AG | A | FB | | G | |
|
| L | SIP | IP | CI | | Aranesp 10 Mikrogramm | 4 syringe(s) | 85.17 | 109.05 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 10µg / 0.4ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 20 Mikrogramm | 4 syringe(s) | 169.11 | 200.35 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 20µg / 0.5ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 30 Mikrogramm | 4 syringe(s) | 254.23 | 292.90 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 30µg / 0.3ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 40 Mikrogramm | 4 syringe(s) | 337.49 | 383.45 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 40µg / 0.4ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 50 Mikrogramm | 4 syringe(s) | 422.82 | 476.25 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 50µg / 0.5ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 60 Mikrogramm | 4 syringe(s) | 507.62 | 568.50 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 60µg / 0.3ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 80 Mikrogramm | 4 syringe(s) | 676.32 | 751.95 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 80µg / 0.4ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 100 Mikrogramm | 4 syringe(s) | 843.40 | 933.65 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 100µg / 0.5ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 300 Mikrogramm | syringe(s) | 628.29 | 699.70 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 300µg / 0.6ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 500 Mikrogramm | syringe(s) | 1039.95 | 1147.40 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 500 µg/ml | Amgen Switzerland AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Aranesp 150 Mikrogramm | 4 syringe(s) | 1259.26 | 1385.95 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 150µg / 0.3ml | Amgen Switzerland AG | A / SL | FB | | G | |
| | SIP | IP | CI | | Aranesp 10 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 10µg / 0.4ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 20 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 20µg / 0.5ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 30 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 30µg / 0.3ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 40 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 40µg / 0.4ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 50 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 50µg / 0.5ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 60 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 60µg / 0.3ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 80 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 80µg / 0.4ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 100 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 100µg / 0.5ml | Amgen Switzerland AG | A | FB | | G | |
| | SIP | IP | CI | | Aranesp 150 Mikrogramm | syringe(s) | PR | PR | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 150µg / 0.3ml | Amgen Switzerland AG | A | FB | | G | |
|
| L | SIP | IP | CI | | Mircera 30 ug / 0.3 ml | 0.3 ml | 54.08 | 75.25 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 30 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 50 ug / 0.3 ml | 0.3 ml | 90.14 | 114.45 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 50 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 75 ug / 0.3 ml | 0.3 ml | 135.22 | 163.50 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 75 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 100 ug / 0.3 ml | 0.3 ml | 180.28 | 212.50 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 100 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 120 ug / 0.3 ml | 0.3 ml | 216.34 | 251.70 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 120 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 150 ug / 0.3 ml | 0.3 ml | 270.42 | 310.50 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 150 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 200 ug / 0.3 ml | 0.3 ml | 360.56 | 408.55 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 200 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Mircera 250 ug / 0.3 ml | 0.3 ml | 450.70 | 506.60 | 10 % | | Injection solution in prefilled syringe: Methoxy Polyethylene Glycol-Epoetinum Beta 250 µg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
|
| | | IP | | | Vafseo 150 mg | 28 | PR | PR | k.A. | | Coated tablets: Vadadustatum 150 mg | Salmon Pharma GmbH | A | FB | | G | |
| | | IP | | | Vafseo 150 mg | 98 | PR | PR | k.A. | | Coated tablets: Vadadustatum 150 mg | Salmon Pharma GmbH | A | FB | | G | |
| | | IP | | | Vafseo 300 mg | 28 | PR | PR | k.A. | | Coated tablets: Vadadustatum 300 mg | Salmon Pharma GmbH | A | FB | | G | |
| | | IP | | | Vafseo 300 mg | 98 | PR | PR | k.A. | | Coated tablets: Vadadustatum 300 mg | Salmon Pharma GmbH | A | FB | | G | |
| | | IP | | | Vafseo 450 mg | 28 | PR | PR | k.A. | | Coated tablets: Vadadustatum 450 mg | Salmon Pharma GmbH | A | FB | | G | |
| | | IP | | | Vafseo 450 mg | 98 | PR | PR | k.A. | | Coated tablets: Vadadustatum 450 mg | Salmon Pharma GmbH | A | FB | | G | |
|
| | | | CI | A | Anaemodoron | 50 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: 3 Active Agents | Weleda AG | D | FB | | G | |
